Quantcast
36.3 C
United States of America
Friday, July 23, 2021
- Advertisement -spot_img

TAG

Continuation

Baricitinib Continuation Rate High in Real-World Practice

Around three-quarters of patients remained on treatment with baricitinib (Olumiant) for rheumatoid arthritis after their first 6-month assessment in an independent analysis of British...

Latest news

- Advertisement -spot_img